Iris Baumgartner, MD; Guenter Rauh, MD; Ann Pieczek, RN; Debra Wuensch, RN; Meredith Magner, BA; Marianne Kearney, BS; Robert Schainfeld, DO; Jeffrey M. Isner, MD
Grant Support: In part by an Academic Award in Vascular Medicine (HL 02824) and grants HL53354 and HL57516 from the National Institutes of Health, Bethesda, Maryland, and by the E.L. Weigand Foundation, Reno, Nevada. Dr. Baumgartner is the recipient of a Swiss National Science Foundation grant. Dr. Rauh is the recipient of a German Humboldt Foundation grant.
Requests for Single Reprints: Jeffrey M. Isner, MD, St. Elizabeth's Medical Center of Boston, 736 Cambridge Street, Boston, MA 02135; e-mail, jisner@opal.tufts.edu.
Requests To Purchase Bulk Reprints (minimum, 100 copies): the Reprints Coordinator; phone, 215-351-2657; e-mail, reprints@mail.acponline.org.
Current Author Addresses: Dr. Baumgartner: University Freiburgstrasse, 3010 Berne, Switzerland.
Dr. Rauh, Ms. Pieczek, Ms. Wuensch, Ms. Magner, Ms. Kearney, Dr. Schainfeld, and Dr. Isner: St. Elizabeth's Medical Center of Boston, 736 Cambridge Street, Boston, MA 02135.
Author Contributions: Conception and design: J.M. Isner.
Analysis and interpretation of the data: I. Baumgartner, G. Rauh, R. Schainfeld, J.M. Isner.
Drafting of the article: I. Baumgartner, G. Rauh.
Critical revision of the article for important intellectual content: A. Pieczek, D. Wuensch, M. Magner, M. Kearney, R. Schainfeld, J.M. Isner.
Final approval of the article: A. Pieczek, D. Wuensch, M. Magner, M. Kearney, R. Schainfeld, J.M. Isner.
Administrative, technical, or logistic support: A. Pieczek, D. Wuensch, M. Magner, M. Kearney, J.M. Isner.
Collection and assembly of data: A. Pieczek, D. Wuensch, M. Magner, M. Kearney.
Vascular endothelial growth factor (VEGF) promotes angiogenesis and vascular permeability. The extent to which VEGF may cause tissue edema in humans has not been established.
To evaluate patients undergoing VEGF gene transfer for evidence of lower-extremity edema.
Prospective consecutive case series.
Hospital outpatient clinic.
62 patients with critical limb ischemia and 28 patients with claudication.
Gene transfer of VEGF DNA.
Semiquantitative analysis of lower-extremity edema.
Lower-extremity edema was observed in 31 of 90 (34%) patients. Edema was less common in patients with claudication than in those with pain at rest (P = 0.016) or ischemic ulcers (P < 0.001), and it was less common in patients with pain at rest than in those with ischemic ulcers (P = 0.017). Treatment was typically limited to a brief course of oral diuretics.
Vascular endothelial growth factor may enhance vascular permeability in humans. At the doses of plasmid DNA used in this study, lower-extremity edema responded to oral diuretic therapy and did not seem to be associated with serious sequelae.
Baumgartner I, Rauh G, Pieczek A, Wuensch D, Magner M, Kearney M, et al. Lower-Extremity Edema Associated with Gene Transfer of Naked DNA Encoding Vascular Endothelial Growth Factor. Ann Intern Med. 2000;132:880–884. doi: 10.7326/0003-4819-132-11-200006060-00005
Download citation file:
© 2019
Published: Ann Intern Med. 2000;132(11):880-884.
DOI: 10.7326/0003-4819-132-11-200006060-00005
Hospital Medicine.